ArticleJournal of cellular and molecular medicine2019

EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.

Fangming Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.